Resmetirom and semaglutide: next-generation therapies for metabolic-associated steatohepatitis. Opportunities, challenges and issues

Expert Review of Endocrinology and Metabolism · Published 2026-08-01 · DOI 10.1080/17446651.2026.2714267

Authors (4)

Luigi E. Adinolfi, Aldo Marrone, Antonio Izzi, Antonio Craxi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Adinolfi, L., Marrone, A., Izzi, A., et al. (2026). Resmetirom and semaglutide: next-generation therapies for metabolic-associated steatohepatitis. Opportunities, challenges and issues. Expert Review of Endocrinology and Metabolism. https://doi.org/10.1080/17446651.2026.2714267

Related articles

• The relationship between iron deficiency and thyroid function: findings from a population-based study in Jordan · Expert Review of Endocrinology and Metabolism · 2026 · Same journal
• Exploring actions of glucagon-like peptide-1 receptor agonists (GLP-1RAs) beyond glucose and obesity control: bone health and osteoporosis · Expert Review of Endocrinology and Metabolism · 2026 · Same journal
• The effects of levothyroxine monotherapy versus combination therapy on quality of life and patient satisfaction · Expert Review of Endocrinology and Metabolism · 2025 · Same journal
• Possible attenuation of gout risk by SGLT-2 inhibitors in patients using thiazide and loop diuretics · Expert Review of Endocrinology and Metabolism · 2025 · Same journal
• The intersection of education and health: schools as a catalyst for childhood obesity prevention · Expert Review of Endocrinology and Metabolism · 2026 · Same journal
• Plasma vitamin D status and its association with biochemical, clinical and humanistic outcomes in diabetic foot infection patients: a prospective observational study in a tertiary healthcare facility · Expert Review of Endocrinology and Metabolism · 2025 · Same journal
• Moving away from BMI: a new era of diagnostic criteria in obesity · Expert Review of Endocrinology and Metabolism · 2025 · Same journal
• Metabolic aspects of polycystic ovary syndrome · Expert Review of Endocrinology and Metabolism · 2026 · Same journal
• Serum asprosin and its association with bone mineral density, oxidative stress, and osteoprotegerin levels in Pakistani women with postmenopausal osteoporosis · Expert Review of Endocrinology and Metabolism · 2025 · Same journal
• Dialysis meets devices: the use of automated insulin delivery in end stage kidney disease and haemodialysis · Expert Review of Endocrinology and Metabolism · 2026 · Same journal